Cargando…
Creating a comprehensive research strategy for cutaneous neurofibromas
OBJECTIVE: Outside of procedural-based methods, there are currently no established medical treatments for cutaneous neurofibroma (cNF), which afflict up to 99% of patients with NF1. Further, adult patients often report cNF are the greatest burden of living with NF1. The Neurofibromatosis Therapeutic...
Autores principales: | Blakeley, Jaishri O., Wolkenstein, Pierre, Widemann, Brigitte C., Lee, James, Le, Lu Q., Jackson, Rhonda, Stathis, Marigo, Verma, Sharad K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703337/ https://www.ncbi.nlm.nih.gov/pubmed/29987129 http://dx.doi.org/10.1212/WNL.0000000000005789 |
Ejemplares similares
-
Clinical trial design for cutaneous neurofibromas
por: Cannon, Ashley, et al.
Publicado: (2018) -
The biology of cutaneous neurofibromas: Consensus recommendations for setting research priorities
por: Brosseau, Jean-Philippe, et al.
Publicado: (2018) -
Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells
por: Ferrer, Marc, et al.
Publicado: (2018) -
Whole Body MRI at 3T with Quantitative Diffusion Weighted Imaging and Contrast-Enhanced Sequences for the Characterization of Peripheral Lesions in Patients with Neurofibromatosis Type 2 and Schwannomatosis
por: Fayad, Laura M., et al.
Publicado: (2013) -
A qualitative study of the impact of plexiform neurofibromas on need fulfilment in adults with neurofibromatosis type 1
por: Heaney, Alice, et al.
Publicado: (2019)